Type 2 Diabetes Treated With Insulin
41
5
6
25
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.3%
3 terminated out of 41 trials
89.3%
+2.8% vs benchmark
17%
7 trials in Phase 3/4
32%
8 of 25 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 25 completed trials
Clinical Trials (41)
In-Home Study With MiniMed™ 780G Pump Automated Control in Type 2-Evaluation of the AHCL System in Adults With Insulin-requiring Type 2 Diabetes
The CARING Study: Creating and Restoring Health Through Nutrition Guidance
Closed-loop in Adults With Type 2 Diabetes
A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes
The Intelligent Diabetes TelemonitoRing Using Decision Support to Treat Patients on Insulin Therapy
Initiation of Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin, in Italy
Patient Centered Multi-Agent Decision Support System (PCM-DSS) for Healthcare Providers
A Study of LY8888AX in Participants Using a Connected Insulin Management Platform
Continuous Glucose Monitor Use in Pregnancy
A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily Injections
Diabetes: Functional Medicine Approach Vs. Usual Care
Reducing Treatment Risk in Older Adults With Diabetes
Study to Evaluate the Safety and Efficacy of Oral Insulin Formulation in Type 2 Diabetes Mellitus Subjects
The Effects of CGM and Connected Pen in T2DM Treated With Multiple Daily Insulin Injections
SAFE-LCD Trial, for Insulin-treated Adults Living With Type 2 Diabetes
Effect on HbA1c of the Initiation of CGM in Adults With Type 2 Diabetes Treated With Basal Insulin in Finland
Anxiety Reduction in Type 2 Diabetes Through Breathing ExercisesPatients With Type 2 Diabetes
Novolog vs. Fiasp Insulin in Non-critically Ill Hospitalized Patients With Type 2 Diabetes Mellitus
Control-IQ Technology in Individuals With Type 2 Diabetes
Evaluation of Diabetes and WELLbeing Programme